10/06/2017 | Nexagen, LLC | Atlanta District Office | CGMP/Dietary Supplement/Adulterated | Not Issued * |
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, October 31, 2017
10/16/2017 | Kim Chemicals Private Ltd. | Center for Drug Evaluation and Research | CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug | Not Issued * |
10/17/2017 | Town and Country Compounding and Consultation Services, LLC | New Jersey District Office | Compounding Pharmacy/Adulterated Drug Products | Not Issued * |
10/18/2017 | Accelerated Analytical Laboratories Inc. | Detroit District Office | CGMP/Finished Pharmaceuticals/Adulterated | Not Issued * |
10/20/2017 | Aztex Enterprises Ltd. | Center for Drug Evaluation and Research | CGMP/Finished Pharmaceuticals/Adulterated | Not Issued * |
10/23/2017 | Panther Sports Nutrition | New Jersey District Office | Unapproved New Drugs/Misbranded | Not Issued * |
Do Biosimilars Require Clinical Trials?
Applied Clinical Trials Online (press release) (blog)-Oct 30, 2017
FDA has mapped out a development pathway for biosimilars that relies primarily on structural analysis and preclinical and clinical pharmacology studies to ...
Drugmaker set to profit from an opioid it said was unsafe
WGNO-Oct 30, 2017
Endo contended that the new Opana ER and its hard coating deterred abuse, but this summer, the FDA disagreed. In June, the regulatory agency concluded that ...
Endo to receive royalties from generic opioid it once called 'unsafe ...
Becker's Hospital Review-21 hours ago
Becker's Hospital Review-21 hours ago
Subscribe to:
Posts (Atom)